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Abstract
Transcriptional enhancers play critical roles in regulation of gene expression, but their identification in the eukaryotic
genome has been challenging. Recently, it was shown that enhancers in the mammalian genome are associated with
characteristic histone modification patterns, which have been increasingly exploited for enhancer identification. However,
only a limited number of cell types or chromatin marks have previously been investigated for this purpose, leaving the
question unanswered whether there exists an optimal set of histone modifications for enhancer prediction in different cell
types. Here, we address this issue by exploring genome-wide profiles of 24 histone modifications in two distinct human cell
types, embryonic stem cells and lung fibroblasts. We developed a Random-Forest based algorithm, RFECS (Random Forest
based Enhancer identification from Chromatin States) to integrate histone modification profiles for identification of
enhancers, and used it to identify enhancers in a number of cell-types. We show that RFECS not only leads to more accurate
and precise prediction of enhancers than previous methods, but also helps identify the most informative and robust set of
three chromatin marks for enhancer prediction.
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Introduction
Enhancers are distal regulatory elements with key roles in the
regulation of gene expression. In higher eukaryotes, a diverse
repertoire of transcription factors bind to enhancers to orchestrate
critical cellular events including differentiation [1,2], maintenance
of cell-identity [3,4] and response to stimuli [5–7]. While
enhancers have long been recognized for their regulatory
importance, the fact that they lack common sequence features
and often reside far away from their target genes has made them
difficult to identify. Computational techniques relying on tran-
scription factor motif clustering or comparative analyses have had
some success in identifying enhancers, but these predictions are
neither comprehensive nor tissue-specific [8–13].
Recently, several high-throughput experimental approaches
have been developed to identify enhancers in an unbiased,
genome-wide manner. The first is mapping the binding sites of
specific transcription factors by ChIP-seq [14]. Because this
approach requires the knowledge of a subset of transcription
factors (TFs) that are not only expressed but also occupy all active
enhancer regions in the cell-type of interest, identification of all
enhancers using this approach is not a trivial task. The second
approach involves mapping the binding sites of transcriptional co-
activators such as p300 and CBP [4,5,15], which are recruited by
sequence-specific transcription factors to a large number of
enhancers [6,16,17]. Since not all enhancers are marked by a
given set of co-activators [18,19], and ChIP-grade antibodies
against these proteins may not always be available, systematic
identification of enhancers by mapping the locations of co-
activators is not generally feasible. A third approach relies on
identifying open chromatin with techniques such as DNase I
hypersensitivity mapping [20]. However, since open chromatin
regions can correspond to not only enhancers, but also silencers/
repressors, insulators, promoters [21,22] or other functionally
unknown sequences occupied by nuclear proteins, this approach
lacks specificity in enhancer identification. Finally, a fourth
approach interrogates covalent modifications of histones [5,23–
26] as it was observed that certain histone modifications form a
consistent signature of enhancers. It is on this approach that the
present work is focused.
Previously, we and others observed that distinct chromatin
modification patterns were associated with transcriptional enhanc-
ers [5,22,27]. Specifically, active promoters are marked by
trimethylation of Lys4 of histone H3 (H3K4me3), whereas
enhancers are marked by monomethylation, but not trimethyla-
tion, of H3K4 (H3K4me1). This chromatin signature has been
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used to develop a profile-based method for enhancer discovery [5].
Both unsupervised [25,28] and supervised learning approaches
have also been employed to exploit chromatin modification-based
differences to identify enhancers. The supervised machine learning
techniques include HMM [8,23], neural networks [24] and genetic
algorithm-optimized SVM [26] based approaches, and have
proved to be improvements over the profile-based method. While
these methods have led to identification of a great number of
enhancers in the human and mouse genomes [3,25,29], the
current computational techniques have thus far been limited by
the small number of the training set samples and limited number
of chromatin modifications examined. Thus, it is possible that
these approaches may not fully capture the entire range of
chromatin modification patterns at enhancer elements. With the
discovery of ever more histone modifications, it is likely that
additional chromatin modifications may distinguish enhancers
from other functional elements in the genome. This additional
data should in principle allow us to answer the key question: what
is the optimal set of modifications required for enhancer
prediction?
Some researchers have tried to tackle this issue by using
algorithms such as simulated annealing [23] or genetic-algorithm
optimization [26]. We sought to develop a method in which the
selection of the optimal set is automatically built into the training-
process and is easily adapted to a large number of features.
As part of the NIH Epigenome Roadmap project, we have
generated genome-wide profiles for 24 chromatin modifications
and DNase-I hypersensitivity sites in 2 distinct cell types- human
embryonic stem cell (H1) and a primary lung fibroblast cell line
(IMR90) [30]. Additionally, we have experimentally determined a
large number of promoter-distal p300 binding sites in each cell
type, providing a rich training set for development of accurate and
robust enhancer prediction algorithms. We now describe a
random-forest [31] based method for integrative analysis of
diverse histone modifications to predict enhancers. We show that
this new algorithm outperforms the existing methods and leads to
the automatic discovery of an optimal set of chromatin modifi-
cations for enhancer predictions.
Results
Prediction of enhancers using random forest and
multiple chromatin marks
Random forests have recently become a popular machine
learning technique in biology [32] due to their ability to run
efficiently on large datasets without over-fitting, and their
inherently non-parametric structure. Since random forests use a
single variable at a time, they can give an automatic measure of
feature importance [33]. Hence, we developed an algorithm based
on this random forest technique for the purpose of enhancer
prediction. Conventional random forests utilize a single scalar
value associated with each feature at each node of the tree. In
order to train a random-forest for enhancer prediction we wanted
to use histone modification profiles at p300 binding sites. Because
the spatial organization of histone modifications along a linear
chromosome can be as informative as their actual levels, they are
better represented as vectors of binned reads. Inspired by recent
modifications to the random-forest approach such as discriminant
random forests [34] or oblique random forests [35] that utilize a
linear classifier at each node, we developed a new vector-based
random forest algorithm RFECS or Random Forest for Enhancer
Identification using Chromatin States (see Methods).
Genome-wide distal p300 binding sites were found using ChIP-
seq in H1 and IMR90 cell-lines. We selected p300 binding sites
overlapping DNase-I hypersensitive sites and distal to annotated
TSS as active p300 binding sites representative of enhancers. We
found 5899 such p300 binding sites in H1 and 25109 such sites in
IMR90 (Table S1,S2), and observed several distinct and diverse
chromatin states using an unsupervised clustering technique,
ChromaSig (fig. 1A,B). All clusters showed enrichment of
H3K4me1 and depletion of H3K4me3 as previously observed
[5]. However, different clusters were characterized by varying
levels of histone acetylation, H3K4me2 or H3K27me3. Clusters
with presence or absence of H3K36me3 may represent genic and
intergenic enhancers respectively. In order to ensure we repre-
sented all these different chromatin states at active p300 binding
sites, we selected a relatively large number of these sites (.5000)
for training as compared to previous methods.
To train the forest, active and distal p300-binding sites (BS)
were selected as representative of the enhancer class. As non-
enhancer classes, we considered annotated transcription start sites
(TSS) that overlap DNase-I, and random 100 bp bins that are
distal to known p300 or TSS (see Methods). The confidence of
each enhancer prediction is given by the percentage of trees that
predict this site to be an enhancer. In general, a genomic region is
predicted as an enhancer if it has a background cutoff greater than
0.5 (.50% trees vote in it’s favor). At higher cutoffs, confidence of
prediction is higher, but fewer enhancers are predicted.
We used Receiver Operating Characteristic (ROC) curves to
determine optimal parameters for our classification algorithm
[36]. In the case of enhancer predictions, we can only obtain an
approximate measure of specificity since we can never be certain
that the randomly selected elements of the non-p300 class are all
true negatives. Hence, in addition to the ROC curves generated
using 5-fold cross-validation, we also verified parameter selection
by comparing the percentage of predicted enhancers at each cutoff
that overlap markers of active enhancers (validation rate) or TSS
(misclassification rate). The markers of active enhancers include
distal DNase-I hypersensitivity sites (HS), p300 binding sites
(excluding those used in training), occupancy by CBP or sequence-
specific transcription factors known to act at embryonic stem cell
enhancers such as NANOG, OCT4 and SOX2.
Author Summary
Enhancers are regions in the genome that can activate the
expression of a gene irrespective of their location with
respect to the gene. Identifying these elements is critical in
understanding regulatory differences between different
cell-types. Since enhancers lack characteristic sequence
features and can be far away from the gene they regulate,
their identification is not trivial. Experimentally determin-
ing the genome-wide binding sites of transcriptional co-
activator p300 is one way of finding enhancers but it can
only identify a subset of enhancers. A few years ago, it was
observed that the binding sites of p300 are marked by
distinctive, post-translational histone modifications. Sever-
al groups have exploited this discovery to predict genome-
wide enhancers based on their similarity to the histone
modification profiles of p300 binding sites. We here report
a novel algorithm for this purpose and show that it has
much greater accuracy than existing methods. Another
unique feature of our algorithm is the ability to automat-
ically deduce the most informative set of histone modifi-
cations required for enhancer prediction. We expect that
this method will become increasingly useful with the
expanding number of known histone modifications and
rapid accumulation of epigenomic datasets for various cell
types and species.
Random Forest for Enhancer Identification
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In the case of Random forests, the main parameter to be
determined is the number of trees. Since the non-enhancer class is
assumed to be several times enriched compared to the enhancer
class in the genome, we select a greater number of non-p300
training sites as compared to p300 sites and this proportion is also
adjusted using the above-described methods. Previous algorithms
[23] as well as empirical observations showed a width of 21 kb to
+1 kb around the p300 binding site as optimal but we further
Figure 1. Histone modification patterns at distal p300 binding sites in H1 and IMR90. A.)Chromatin states for p300 binding sites in H1
cells. B.)Chromatin states for p300 binding sties identified in IMR90 cells, identified by clustering using ChromaSig [48]. The heatmap shows RPKM-
normalized histone modification levels in 100 bp bins from 25 to +5 kb along p300 binding sites overlapping DHS and distal to known TSS.
doi:10.1371/journal.pcbi.1002968.g001
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verified this selection by cross-validation in the H1 cell-type (fig.
S1A). The difference in cross-validation curves using a width of
0.5 kb or 1 kb is not obvious on the cross-validation curve while a
width of 1.5 kb clearly shows a sharp drop in the area under the
ROC curve (fig. S1A). When we further made enhancer
predictions using all three widths (fig. S1B,C), it can be seen that
a width of 1 kb on either side shows best validation and
misclassification rates as compared to 0.5 or 1.5 kb widths.
Enhancer predictions in H1 and IMR90 cells
To determine the optimal number of trees for the random-
forest, we examined the area under the ROC curve in H1 and
IMR90 and found both to be stable beyond 45 trees (fig. 2A,B). In
order to verify this further, we made enhancer predictions using
various number of trees such as 45, 65 and 85 and compared the
validation and misclassification rates (fig. S2A–D). While H1
appeared to show no change at all (fig. S2A,,C) IMR90 showed a
slight improvement from 45 to 65 trees (fig. S2B,D). In the end, we
selected 65 trees for training the random forest as it appeared to be
optimal for both cases. The training-set ratio of p300 to non-p300
was set at 1:7 since the ROC curve did not appear to change much
beyond this ratio. (fig. S2E,F)
In order to estimate the accuracy of the enhancer prediction by
RFECS, we applied this algorithm to chromatin profiles of 24
marks obtained in H1 and IMR90. We then calculated the
validation rate as the percentage of predicted enhancers overlap-
ping with DNase-I hypersensitivity sites and binding sites of p300
and a few sequence specific transcription factors known to function
in each cell type (true positive markers). We also computed the
misclassification rate as the percentage of predicted enhancers
overlapping with known promoters. These overlaps were com-
puted using a window of 22.5 to +2.5 kb. Incase, both a true
positive marker as well as promoter lay within this window, the
criteria used to decide if the enhancer was ‘‘validated’’ or
‘‘misclassified’’ is discussed in detail in the Methods section. In
H1 cells, we obtained a total of 55382 predicted enhancers at the
lowest voting cutoff of 0.5. Over 80% of these predicted enhancers
overlap with distal DNase-I hypersensitive sites and the binding
sites of p300, NANOG, OCT4 and SOX2. Upon randomly
generating enhancer predictions in the H1 genome 100 times, we
found the average validation rate to be 18.43% and the actual
validation rate of 80% to be highly significant with a one-sided t-
test p-value of 10‘-256. Additionally, we found that 5% of them
overlap with UCSC TSS, indicating a low misclassification rate of
5% (fig. 2C,E, in red). A similar high level of validation rate and
low misclassification rate were observed when RFECS was applied
to IMR90 cells, where 83581 enhancers were predicted with a
validation rate of 85%(average random validation rate = 16.13%,
pvalue = 2610‘-279), and misclassification rate of 4% (fig. 2D,F).
Thus, RFECS appears to accurately predict putative enhancer
sequences based on chromatin modification state of the genome.
We next tried to assess the linear resolution of RFECS
predictions. We calculated the distance between the predicted
enhancers and locations of enhancer markers such as DNase-I
hypersensitive sites, or p300 binding sites in each cell type, and
found that the majority of predicted enhancers are within 200 bp
of these sites (fig. S3A,B). In H1, nearly 62% of enhancers lie
within 200 bp of an enhancer marker site (fig. S3A), while in
IMR90 this value is around 70% (fig. S3B). Thus, the majority of
enhancer predictions also show a high distance resolution in terms
of proximity to the validation marker.
We also confirmed that our enhancer predictions showed an
activation of gene expression in the proximal TSS. In order to do
this, we compared RNA-seq datasets (Wei Xie et al., manuscript
under revision) in H1 and IMR90 using edgeR [37] to identify
H1-specific and IMR90-specific TSS. Then we identified
enhancer predictions specific to either H1 or IMR90 using a
filter distance of 2.5 kb. When we look at the average distribution
of H1-specific enhancers they are clearly enriched in the vicinity of
H1-specific TSS as compared to either non-specific TSS or
IMR90-specific TSS (fig. S3C) and this enrichment is found to
significant at distances up to at least 500 kb using a Wilcoxon test
(p-value,10‘-6). Similarly, in the case of IMR90-specific enhanc-
ers, we observe them to be more enriched in the proximity of
IMR90-specific TSS as compared to H1-specific TSS (fig. S3D, p-
value,10‘-23).
As further evidence that RFECS accurately predicts enhancers,
chromatin modifications at the predicted enhancers showed
presence of all chromatin states observed in the training sets
comprised of a subset of distal p300 binding sites (fig. 1). In H1,
clusters 1,2 and 8 of enhancer predictions (fig. S4) are similar to
clusters 1–3 of the p300 binding sites (fig. 1A), clusters 3–4 appear
to correspond to cluster 5 of p300 BS, while clusters 5–6 look like
cluster 4 of p300 BS. In IMR90, similar trends could be observed
when comparing chromatin states at enhancer predictions (fig. S5)
to those of p300 binding sites (fig. 1B). Further, it can be observed
that clusters 3–6 of the enhancer predictions in H1 (fig. S4) that
have weaker acetylation and/or enrichment of H3K27me3 also
tend to have lower voting percentage of trees.
In summary, we showed that RFECS accurately predicted
enhancers in the two cell lines H1 and IMR90 using a set of 24
chromatin modifications. These enhancers showed high validation
rates, low misclassification rates and sharp linear resolution.
Random forest trained on one cell-type can accurately
predict enhancers in other cell-types
To make enhancer predictions, our approach requires a
construction of a random forest trained on promoter-distal p300
binding sites. It is time-consuming and expensive to create a new
training set for enhancer prediction in each new cell type, so it is
desirable to use a random forest developed in one cell type to
predict enhancers in another. To evaluate the feasibility of such
approach, we first trained a random-forest using chromatin
modification profiles obtained in H1, and then applied it to the
IMR90 cells. Compared to RFECS predictions using IMR90
chromatin profiles as training set, RFECS predictions using H1
training dataset reduces the validation rate by ,5–8% and
increases the misclassification rate by,2% (fig. 2C,E black vs red).
Similarly, we also developed a random forest using the IMR90
data as the training set and then applied it to H1. This led to an
average reduction of 2–3% in validation rate (fig. 2D, black vs
red). Therefore, RFECS trained using one cell type may be
applied to a different cell type, albeit with slightly lower accuracy.
We sought to examine if this moderate decrease in performance
was largely due to cell-type specific differences or was within the
limits of technical or biological variability between replicates. To
this end, we trained a random forest on one replicate of a cell-type,
and made predictions on the other replicate of the same cell type.
RFECS trained on IMR90 and then applied to the replicate 1 of
the H1 profiles (blue dot vs asterisk) actually showed a higher
validation rate and lower misclassification rate than RFECS
trained using replicate 2 of H1 (fig. 2C,E), while similar
performance was observed with enhancer predictions on replicate
2 of H1 independent of whether the random-forest was trained on
H1 replicate 1 or IMR90 (green dot vs asterisk). Similar trends
were observed when comparing predictions made on individual
replicates of IMR90 using either H1-training or training on the
other replicate (fig. 2D,F). In conclusion, predicting enhancers
Random Forest for Enhancer Identification
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Figure 2. Performance of RFECS for enhancer predictions in H1 and IMR90 cells. Area under the 5-fold cross-validated ROC curve decreases
with increase in number of trees stabilizing gradually in A.)H1 and B.)IMR90 cells. C.)Validation Rate of enhancer predicted in H1 cells, as measured by
overlap with DNase-I HS and binding sites of p300, NANOG, OCT4 and SOX2. D.)Misclassification Rate of enhancer predicted using RFECS in H1 as
measured as overlap of UCSC TSS, E.)Validation Rate of enhancers predicted by RFECS in IMR90 as measured by overlap with DNase-I HS or p300
binding sites in the same cells. F.)Misclassification Rate of enhancers predicted by RFECS in IMR90 as measured by overlap with UCSC TSS, versus total
number of enhancers (upto 40000 enhancers) determined by taking different enrichment cutoffs, are shown for forest trained in the same cell type
(?red), forest trained in other cell type and predictions made on modifications with averaged RPKM (?black), replicate 1 only (?blue), and replicate 2
only (?green). Training on one replicate and prediction on the other replicate of the same cell-type are indicated by asterisks.
doi:10.1371/journal.pcbi.1002968.g002
Random Forest for Enhancer Identification
PLOS Computational Biology | www.ploscompbiol.org 5 March 2013 | Volume 9 | Issue 3 | e1002968
using the random forest built from a different cell type exhibits a
modest decrease in performance compared to a same-cell training
set. However, this decrease in performance is comparable to the
decrease that can arise due to variability between two replicates of
the same cell-type.
Optimal set of chromatin marks required for enhancer
prediction
With the increasing number of histone modifications being
discovered and mapped, determination of the relative importance
of each mark in defining genomic elements is important. An out-
of-bag measure of variable importance is a natural by-product of
random forest classification scheme [33] wherein the relative
importance of each feature is assessed as the increase in
classification error upon permutation of feature values across
classes. In both H1 and IMR90, the variable importance was
assessed for random forests trained on 5 cross-sections of data for
each of the 2 sets of replicates individually as well as the set of
averaged replicates. Upon ranking histone modifications by
variable importance, it is apparent that H3K4me1 and
H3K4me3 are the top 2 most robust modifications across
replicates and cross-sectional samples in both cell types, followed
by H3K4me2 (fig. 3A, B). This indicates that these 3 modifications
maybe the most informative in the prediction of enhancers in any
unknown cell type as well.
Beyond the top 3 modifications, there is variability among the
cell types. In IMR90, the other modifications appear to contribute
almost equally, while in H1 there is a much clearer difference in
variable importance. These differences are supported by correla-
tion analyses in H1 and IMR90 (fig. 3C,D). In H1, several
modifications are highly correlated, which could explain the larger
differences in variable importance, as only a few variables maybe
needed to form a non-redundant set. In IMR90, the correlations
are lower and hence each of the modifications may contribute
non-redundant information and thus contribute equally to the
variable importance. Modifications that cluster together in both
H1 and IMR90 (shown in the same non-black colors, fig. 3C,D)
suggest cell-type independent redundancy.
Having established the relative importance of each histone
modification in predicting enhancers, we next examined the
accuracy of predictions using different sets of modifications.
Validation rates obtained by using the minimal set of H3K4me1-3
is within 2% of that for all 24 modifications in H1 (fig. 4A).
Furthermore, this minimal set performs considerably better than
the more conventionally selected set of H3K4me1 and H3K4me3
[3,5] and at times, H3K27ac [38,39] (fig. 4A,B, in black and blue).
The set of H3K4me1-2-3 is more comparable to H3K4me1-
H3K4me3-H3K27ac in IMR90 but does have a slightly lower
misclassification rate (fig. 4D). In both cases the use of the minimal
set of 3 modifications shows a much closer resemblance in
performance to all 24 modifications than to the set of 2 marks
H3K4me1 and H3K4me3 (fig. 4A–D).
It can also be observed that in conjunction with H3K4me1 and
H3K4me3, using H3K4me2 picks up a larger proportion of
enhancers with weaker acetylation enrichment as compared to
H3K27ac (fig. S4,S5), supporting our prediction of the minimal
set.
We also made enhancer predictions using all possible combi-
nations of 3 modifications in chromosome 1 for replicate 1 and
replicate 2 of H1. The average validation rate for a fixed range of
enhancers was compared across replicates and it can be seen the
set corresponding to H3K4me1, H3K4me2 and H3K4me3
(marked in *), is the highest performing combination common to
both replicates (fig. 4E). We also found the performance of the
combination of H3K27ac with H3K4me1 and H3K4me3 appears
to be comparable in this case (3, fig. 4E), validating the use of
H3K27ac as a feature for enhancer prediction when H3K4me2 is
not available. Some of the worst performing combinations include
H3K9me3 and H4K20me1 (4 and 5, fig. 4E), which also show up
as variables with least importance in fig. 3A.
In many currently existing datasets, H3K27ac is the more
commonly sequenced histone modification as compared to
H3K4me2 due to it’s perception as a marker of active enhancers.
While using H3K4me2 may improve enhancer prediction in some
cell-types, use of H3K27ac in addition to H3K4me1 and
H3K4me3 marks does show considerable improvement over
using just the top 2 marks H3K4me1 and H3K4me3 (fig. 4A–D).
Hence, for many of the currently existing datasets, we could use
H3K4me1, H3K4me3 and H3K27ac as the features in our
random-forest with satisfactory performance.
Overall, these comparisons indicate the suitability of selecting
H3K4me1, H3K4me2 and H3K4me3 as three minimal chroma-
tin marks for purposes of enhancer prediction. Additional
chromatin modifications required for improving upon enhancer
predictions may depend on cell-type specific characteristics, as
indicated by the differences in variable importance between H1
and IMR90 (fig. 3A,B).
Comparison of RFECS with other enhancer prediction
methods
We next asked if our enhancer prediction algorithm performed
better than several other current techniques for enhancer
prediction – CSIANN, ChromaGenSVM and Chromia
[23,24,26,39]. In previous studies, CSIANN and Chroma-
GenSVM were applied on the histone modification dataset in
CD4 T-cells [24,26,39]. In order to make a comparison of
performance of our method with previous approaches, we applied
RFECS to the CD4+ T cell dataset as well and determined
parameters using cross-validation (fig. S6). Using H3K4me1,
H3K4me3, and H3K27ac, CSIANN made 21832 predictions [39]
and ChromaGenSVM method made 23574 predictions [26]. We
made enhancer predictions using H3K4me1, H3K4me3 and
H3K27ac with RFECS as well as Chromia [23]. Cutoffs were
selected that yielded a similar number of enhancer predictions for
both Chromia (21895) and RFECS (22947) (fig. 5A), so as to make
a fair comparison across methods.
To compare these different sets of enhancer predictions, we
computed validation rates by comparing them to TSS-distal
DNase-I hypersensitive sites, p300 binding sites, and CBP binding
sites and misclassification rates by comparing to known UCSC
TSS using a window of 22.5 kb to +2.5 kb as described in the
methods. (fig. 5A). The validation rate of RFECS predictions is
around 70%, which is considerably higher than the other three
methods (57% ChromaGenSVM, 51% CSIANN, 60% Chromia).
Further, the misclassification rates of RFECS is less than 7%,
much lower than the 27%, 35% and 15% rates of Chroma-
GenSVM, CSIANN and Chromia, respectively. These results
suggested that overall procedure for RFECS, including selection of
training set as well as training and prediction using the vector-
random-forest, performs better than currently available techniques
for enhancer prediction.
In the above comparison, we selected our enhancer-represen-
tative training set as p300 peaks called using MACS [40] that were
distal to known UCSC TSS and overlapped DNase-I locations
while CSIANN and ChromaGenSVM used a training-set of p300
peaks called using SICER previously [41]. We also wanted to
compare the performance of the different algorithms on our own
datasets using the same training-set to evaluate the performance of
Random Forest for Enhancer Identification
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the random-forest based part of the algorithm. To achieve this, we
ran the various enhancer prediction methods on H3K4me1,
H3K4me2 and H3K4me3 datasets of H1, with help from the
author of ChromaGenSVM [26] (fig. 5B). We tried to make the
pre-processing stages of the various algorithms as consistent as
possible by merging several replicates of each histone modification
Figure 3. Out-of-bag variable importance of histone modifications in enhancer prediction. The average variable of histone modifications
across 5 cross-sections of data in 2 sets of replicates as well as averaged replicates using all 24 modifications in A.)H1 and B.)IMR90 cells. Out-of-bag
variable importance was calculated from the random-forest based classification of p300 binding sites against TSS+genomic background. Robust
appearance of H3K4me1, H3K4me3 and H3K4me2 among the most important marks across replicates and cell types, indicates these may form a
minimal set for prediction of enhancers. Differences observed in correlation clustering of the same 24 modifications in C.)H1 and D.)IMR90 explain
some of the differences in ordering of variables in the two cell types. Same non-black colors of modifications indicate clusters that co-occur in both
cell-types.
doi:10.1371/journal.pcbi.1002968.g003
Random Forest for Enhancer Identification
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Figure 4. Validation rate and Misclassification rate of enhancers predicted using RFECS in H1 and IMR90. A.) Validation Rate in H1
measured by overlap with DNase-I HS, p300, NANOG, OCT4 or SOX2, B.) Misclassification Rate in H1 measured as overlap of UCSC TSS, C.) Validation
Rate in IMR90 measured by overlap with DNase-I HS or p300, D.) Misclassification Rate in IMR90 measured as overlap of UCSC TSS, versus total
number of enhancers determined by taking different enrichment cutoffs, are shown for all 24 modifications (red), predicted minimal set of H3K4me1/
H3K4me2/H3K4me3 (green) and conventionally used marks H3K4me1/H3K4me3 (black) or H3K4me1/H3K4me3/H3K27ac (blue). E.) Comparison of
average validation rates for enhancer predictions using all combinations of 3 histone modifications for 2 replicates of H1.
doi:10.1371/journal.pcbi.1002968.g004
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files and input files into single bed files and randomly selecting a
smaller subset of p300 peaks for training, since these were the
requirements of the other algorithms such as CSIANN and
ChromaGenSVM. Incase of CSIANN, the selection of back-
ground was hard-coded in the software but in all other cases we
used our own background training set as well. In fig. 5B, it can be
observed that RFECS shows a maximum validation rate of around
82.8% as compared to 66.8%, 57.7% and 63.3% for Chroma-
GenSVM, CSIANN and chromia respectively. Further, RFECS
showed the lowest misclassification rate of 4.9% as compared to
8.3%, 36,7% and 10.1% rates for the above-mentioned cases.
Hence, the improvement in performance due to RFECS cannot
be solely attributed to method of selecting the training-set. In
summary, RFECS shows considerably improved performance
over existing enhancer-prediction algorithms in two very different
datasets and hence can be considered an advance in the field.
Prediction of enhancers in multiple human cell-types
Comparing enhancer predictions across diverse cell-types can
contribute to understanding differences in regulatory mechanisms
between cell-types. The ENCODE dataset is an example of a
collection of high-throughput datasets such as histone modifica-
Figure 5. Comparison of enhancer predictions using RFECS, ChromaGenSVM, CSIANN and Chromia. A.) In CD4. True positive rates were
measured as overlap with either DNase-I hypersensitive sites (DHS), p300 or CBP binding sites, while false positives were measured as overlap with
UCSC TSS. B.) In H1. True positive rates were measured as overlap with either DNase-I hypersensitive sites (DHS), p300 or transcription factor binding
sites such as NANOG, OCT4 and SOX2, while false positives were measured as overlap with UCSC TSS.
doi:10.1371/journal.pcbi.1002968.g005
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tions and transcription factor binding data that are available for
multiple cell-types [42]. Having a set of high-confidence enhancer
predictions in these cell-types would be a valuable resource.
We trained our random forest on the p300 ENCODE data in H1
and made enhancer predictions in 12 ENCODE cell-types using the
three marks H3K4me1, H3K4me3 and H3K27ac since these were
available for all the cell-types. Validation rates were assessed based
on overlap with existing DNAse-I hypersensitivity data while
misclassification rates were calculated based on overlap with UCSC
TSS. It can be seen that the majority of cell-types show high
validation rates between 80 and 95%, while the misclassification
rates lie within acceptable levels of 2–7% (fig. 6A,B).
In order to compare enhancers across cell-types, it is preferable
to have enhancer predictions with the same level of confidence. To
determine the appropriate cutoff for multiple number of cell-types,
we calculate a False Discovery rate by randomly permuting
100 bp bins across the genome and computing the ratio of
enhancers predicted in permuted data/enhancers predicted in real
data for various cutoffs of voting percentages. In fig. 6C, it can be
seen that different cell-types show a different relationship with
FDR. For example, at an FDR of 5%, the voting percentage for
GM12878 (solid dark blue) is 0.74, for Nhek (dashed cyan) 0.64
and for Hsmm (solid yellow) it is 0.56.
Using an FDR of 5%, we obtained a consistent set of high-
confidence enhancer predictions in the 12 ENCODE cell-types. In
fig. 6D, the numbers of enhancer predictions in each cell type is
shown above the bar. The validation rates (in red) are above 90%
for all cell-types except H1, Hepg2 and GM12878. In H1 and
Hepg2, the numbers of DNase-I hypersensitivity sites are relatively
less, i.e. ,150 to 177K as compared to ,230 to 380K in the other
cell-lines. This may explain the somewhat lower validation rate in
these two cell-types. GM12878 appears to be an outlier and we
suspect that enhancer predictions may potentially be improved in
this cell line by using a different training set.
In summary, we obtained a high-confidence set of enhancer
predictions in multiple ENCODE cell-lines with the same level of
confidence. This will enable more rigorous comparisons of
regulatory characteristics of these cell-types in the future.
Figure 6. Enhancer predictions in ENCODE cell-lines using RFECS. A.)Validation Rate in the 12 cell-types measured by overlap with DNase-I
HS, B.)Misclassification Rate in the cell-types measured as overlap of UCSC TSS, C.)Average false discovery rate (FDR) over the 22 autosomal
chromosomes for each cell-type plotted as a function of voting percentage of trees, D.)Validation rate and misclassification rate for each cell-type at a
FDR of 5% with number of enhancer predictions shown above the bar.
doi:10.1371/journal.pcbi.1002968.g006
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Discussion
We describe here a novel machine-learning algorithm to
accurately predict enhancers in a genome-wide manner based
on chromatin modifications. We trained this algorithm using novel
p300 training sets in H1 and IMR90 and 24 chromatin
modifications in each cell-type. We showed that models trained
on one cell-type could be effectively applied on another cell-type.
Random forests enable detection of the most informative features
required for a classification task. In the case of enhancer
prediction, we identified a set of 3 histone modifications that
appeared to be the most informative and robust across cell-types
and replicates. Such an approach can once again be applied when
the number of genome-wide modification maps is expanded in
various different cell types and the most informative set of
modifications can be further refined. We show that RFECS
outperforms other machine-learning based prediction tools in
CD4+ T cells, and can be applied in the future to multiple cell
types. We successfully applied our enhancer prediction tool to 12
cell-lines in the publicly available ENCODE database and
obtained a set of enhancers with a consistently high level of
confidence across the cell-types.
In the future, we could potentially adapt the RFECS method to
detect other regulatory genomic elements that can be observed to
have a distinct chromatin signature and find the minimal set of
chromatin marks for this purpose. The ability to detect diverse
patterns of features within the training set indicates that the
RFECS approach could be used to train on a composite training
set comprised of different transcription factors. Combining
information from different enhancer-binding proteins may im-
prove prediction of regulatory elements. Random forests are non-
parametric and have been shown to integrate a large number of
diverse features. This could suggest the addition of other discrete
and continuous data types such as sequence or motif based




The H1 and IMR90 datasets used in this study were generated as
part of the NIH Roadmap Epigenome Project and have been
released to the public prior to publication (http://www.genboree.
org/epigenomeatlas/multiGridViewerPublic.rhtml). Briefly, 24
chromatin modifications in human embryonic stem cell (H1) and
primary lung fibroblast cells (IMR90) were generated by the Ren
lab and deposited under the NCBI Geo accession number
GSE16256. Additionally, two replicates of H3K9me3 datasets
deposited under Geo accession numbers GSM818057 and
GSM42829 were used. Genome-wide binding data for p300 in
H1 and IMR90, and transcription factors NANOG, SOX2 and
OCT4 in H1 were generated in the Ren lab using ChIP-seq and
deposited under accession numbers GSE37858, GSE18292 and
GSE17917 respectively. Any data mapped to hg18 was converted to
hg19 using liftover tools [43]. The DNase-I hypersensitivity datasets
for H1 and IMR90 were produced by the Stammatoyanopoulos
group at UW [44]. IMR90 DNase-I raw data may be accessed using
GSM468792 and narrow peak calls are attached as supplemental
information. Narrow DNase-I peaks in H1 were downloaded
from UCSC ENCODE page (http://hgdownload.cse.ucsc.edu/
goldenPath/hg19/encodeDCC/wgEncodeUwDnase/)
For CD4, previously generated datasets for p300 [41], CBP [41]
and DNase-I [21] data as well as histone modifications [45,46]
were used. Histone modification data and DNase-I hypersensitiv-
ity data for the 12 ENCODE cell-lines was downloaded from
http://genome.ucsc.edu/ENCODE/downloads.html.
Data normalization for histone modifications
The ChIP-seq reads for the histone modification as well as
corresponding input were binned into 100 bp intervals. The
binned modification file was normalized against the binned input
file using an RPKM (Reads per kilobase per million) measure [47].
In the case of 2 or more replicates, the RPKM- level for each bin is
averaged to get a single histone modification file, in order to
minimize batch-related differences.
Determination of binding sites for p300 and other
transcription factors
MACS [40] software was used to call peaks for p300, CBP and
any other TF such as NANOG, SOX2 and OCT4. ChIP-seq
input files were used as background and parameters of mfold = 20
and default p-value cutoffs were used. Peak calls are available
as supplemental files. In case of the p300 and CBP binding sites
used to validate enhancer predictions in CD4, we included the
regions of enrichment that were previously published as well
[41]
Construction of random forest
We constructed the forest using the concept of binary
classification trees, with each feature being a 20-dimensional
vector of 100 bp bins from 21 to +1 kb along the genomic
element. At each node in the tree, a linear classifier was
constructed using the Fischer Discriminant approach using the
histone modification vector, allowing for utilization of shape as
well as abundance information (fig. S7A). The utilization of the
linear discriminant at each node was inspired by the recent
development of methods such as the discriminant random-forests
[34] and oblique random forests [35]. The Vector-Random forest
algorithm was implemented in MATLAB (MATLAB 7.14.0.739,
The Mathworks Inc., Natick, MA, 2012a) as the function
‘‘multiclasstree’’ and utilizes functions from the ‘‘classregtree’’
and ‘‘classify’’ functions of MATLAB, implementing decision trees
and linear discriminants respectively. The code used for RFECS
can be downloaded from: http://enhancer.ucsd.edu/renlab/
RFECS_enhancer_prediction/
Training the random forest for enhancer predictions
Enhancer prediction involved two stages, which are classifica-
tion of p300 vs non-p300 and peak-calling.
1) Classification of p300 vs non-p300 for enhancer prediction
purposes
i. Training
In the first stage, a forest was constructed with two classes – a
class containing p300 binding sites and a second class with an
equal number of TSS and x times the number in random
background sequences, where x= 9 for CD4 and x=7 for H1
and IMR90.
ii. Prediction
In order to make predictions, each 100 bp bin along a
chromosome is assigned either enhancer or non-enhancer
status. The output from the forest is in the form of percentage
of trees predicting a 100 bp bin to be one element or another.
Only bins that have .50% trees voting for the enhancer class,
are considered for further analysis.
2) Peak-calling
Using the random forest previously trained to predict whether a
100 bp bin along a chromosome is an enhancer or not often yields
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values .50% for regions on either side of the exact location of a
p300-binding site. However, the percentage of trees voting in favor
of p300 decreases symmetrically on either side of the actual peak
(fig. S7.B). This property is used to select the bin with maximum
voting percentage within a certain peak-filtering distance as the
enhancer peak based on the assumption that the flanking regions
are part of this same enhancer.
Computation of variable importance
A major advantage of the random forest is the inherent ability to
select more important variables versus less important ones. In
order to compute the order of variable importance, in this case,
the importance of individual histone modifications for making
enhancer predictions, we use an out-of-bag measure of
variable importance [33] implemented in Matlab as the function
oobVarImp.
Application of variable importance to determine the
minimal set of modifications required to predict
enhancers
Based on the ordering of the variable importance across 5
different cross-sections of the training dataset of multiple replicates
and cell types, certain modifications may always be observed to
have priority. Due to the non-redundant nature of the ordering of
variables as well as their robustness across replicates and samples,
these modifications maybe selected as the most informative ones
that are required to make enhancer predictions.
Validation of enhancer predictions
Cross-validated ROC curves were used to estimate parameters
for use within the same algorithm. However, comparisons across
different algorithms may be biased depending upon the compo-
sition of the training set, so we validated enhancer predictions as
described below.
Enhancer Predictions outputted from the random forest
predictor have background enrichment scores of ‘‘voting percent-
age’’ ranging from 0.5 to 1 to enable detection of enhancers at
different levels of confidence. At higher cutoffs, confidence of
prediction is higher, but fewer enhancers are detected. The
availability of large-scale datasets such as DNase-I hypersensitive
sites, p300 binding sites, CBP binding sites and transcription factor
binding sites enabled an estimate of the number of true positives at
every cutoff. Further, the number of enhancers misclassified as
TSS at each cutoff was also determined. Within the same cell type,
an enhancer prediction method that performs better, should pick
up more true positive validation markers and fewer TSS, given the
number of predictions are the same.
Predicted enhancers are classified as ‘‘validated’’, ‘‘misclassi-
fied’’ or ‘‘unknown’’ based on the criteria below. True Positive
Markers (TPM) refer to DNase-I hypsersensitivity site, p300, CBP
and Transcription factor binding sites.
1. If the nearest TPM lies within 2.5 kb of the enhancer and the
nearest TSS is greater than 1 kb away from the TPM, the
enhancer is ‘‘validated’’
2. If a TSS lies within 2.5 kb of the enhancer, and the nearest
TPM is either greater than 2.5 kb away from the enhancer or
within 1 kb of the TSS, the enhancer is ‘‘misclassified’’
3. If there is no TPM or TSS within 2.5 kb of the enhancer, it is
‘‘unknown’’.
Correlation graphs
The Pearson correlation coefficient between any two modifica-
tions was computed for RPKM-normalized histone modification
reads between 21 to +1 kb for all elements within the selected
training set. The correlation patterns of each histone modification
was used to cluster the modifications and order them using
MATLAB tools.
This enabled visualization of which modifications are the most
similar in their correlation patterns. In the ordering of variable
importance, if certain variables showed up as important in two
different cell types, the redundancy based on their correlation plots
could be used to explain away this variability.
Visualization of chromatin modification patterns
ChromaSig [48] was used to cluster histone modification
patterns along p300 binding sites and predicted enhancers using
modification width as 4 kb. The resulting clusters were then
visualized using Java TreeView [49].
Supporting Information
Figure S1 Determination of optimal peak width for
training of RFECS predictor in H1 cells. A.)ROC curves for
5-fold cross-validation at different proportions of peak widths of
20.5 to +0.5 kb, 21 to +1 kb and 21.5 to 1.5 kb around training
set sites. B.)Percentage of enhancers validated by true positive
markers at different numbers of enhancers determined by various
cutoffs (Validation rate or VR curve). C.)Percentage of enhancers
misclassified as TSS at different numbers of enhancers determined
by various cutoffs. (Misclassification rate or MR curve). Overall,
the width of 21 to +1 kb appears to show the best performance as
expected based on previous observations.
(EPS)
Figure S2 Determination of parameters for training of
RFECS predictor in H1 and IMR90 cells. A,B.)Percentage of
enhancers validated by true positive markers at different numbers
of enhancers determined by various cutoffs (Validation rate or VR
curve) in A.)H1 and B.)IMR90, for different number of trees.
C,D.)Percentage of enhancers misclassified as TSS at different
numbers of enhancers determined by various cutoffs. (Misclassi-
fication rate or MR curve) in C.)H1 and D.) IMR90, for different
number of trees. . VR and MR curves do not appear to change
much beyond 45 trees, confirming the selection of 65 trees as valid.
E,F.)ROC curves for 5-fold cross-validation at different propor-
tions of training set ratios of p300:non-p300 in E.) H1 and F.)
IMR90. ROC curves appear to be most stable beyond the ratio of
1:7.
(EPS)
Figure S3 Linear resolution and association with ex-
pression of genes for enhancer predictions in H1 and
IMR90. Distribution of distances between predicted enhancers
and known markers of active enhancers such as DNase-I
hypersensitivity sites, p300 and transcription factor binding sites
in A.)H1 and B.)IMR90. Distribution of average number of cell-
type specific enhancers around the TSS specific to either H1
(blue), IMR90 (red) or non-specific (black) where the cell-type is
C.)H1 or D.)IMR90.
(EPS)
Figure S4 Histone modification patterns at enhancer
predictions in H1. Clustering was performed using ChromaSig.
Java treeview-generated Heatmap shows RPKM-normalized
histone modification levels in 100 bp bins from 25 to +5 kb
along genomic elements overlapping enhancers in Chromosome1
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predicted using all 24 modifications. On the left panel, the state
number and sizes are indicated. On the right panel, percentage of
each state detected by different combinations of histone modifi-
cations or H1-trained forest are shown. Also shown are the
distribution of background cutoffs associated with each chromatin
state.
(TIF)
Figure S5 Histone modification patterns at enhancer
predictions in IMR90. Clustering was performed using
ChromaSig. Java treeview-generated Heatmap shows RPKM-
normalized histone modification levels in 100 bp bins from 25 to
+5 kb along genomic elements overlapping enhancers in Chro-
mosome1 predicted using all 24 modifications. On the left panel,
the state number and sizes are indicated. On the right panel,
percentage of each state detected by different combinations of
histone modifications or H1-trained forest are shown. Also shown,
are the distribution of background cutoffs associated with each
chromatin state.
(TIF)
Figure S6 Determination of parameters for training of
RFECS predictor in CD4 T-cells. A.)Area under the 5-fold
cross-validated ROC curve decreases with increase in number of
trees stabilising gradually B.) Percentage of enhancers validated by
true positive markers at different numbers of enhancers determined
by various cutoffs (Validation rate or VR curve) and C.) Percentage of
enhancers misclassified as TSS at different numbers of enhancers
determined by various cutoffs. (Misclassification rate or MR curve),
for 41, 61 and 81 trees. VR and MR curves do not appear to change
much beyond 61 trees, confirming the selection of 81 trees as valid.
D.) ROC curves for 5-fold cross-validation at different proportions of
training set ratios of p300:non-p300. ROC curve does not appear to
change much beyond a ratio of 1:9 E.) Validation Rate curve for
training set ratios of 1:9 and 1:11. F.) Misclassification Rate curve for
training set ratios of 1:9 and 1:11. The VR and MR curves validate
the choice of 1:9 as an appropriate training set ratio.
(EPS)
Figure S7 Training of RFECS for enhancer prediction.
A.)Example of the vector-based random-forest classifying p300
binding sites and TSS using histone modifications. B.)Average
percentage of trees voting in favor of the enhancer class around a
p300-binding site. Percentage of trees in the random forest
predictor that vote in favor of the enhancer class decrease
symmetrically with increasing distance from the p300-binding
peak. This property is used to develop a peak-calling method that
can predict the most probable location of the enhancer.
(EPS)
Table S1 All p300 binding-sites called using MACS in
H1 cells (hg19).
(XLS)
Table S2 p300 binding sites in H1 overlapping DNase-I
hypersensitivity sites and distal to known UCSC and
Gencode TSS.
(XLS)
Table S3 Transcription factor binding sites in H1.
(XLS)
Table S4 H1 enhancers predicted using all 24 modifi-
cations.
(XLS)
Table S5 All p300 binding-sites called using MACS in
IMR90 cells (hg19).
(XLS)
Table S6 p300 binding sites in IMR90 overlapping
DNase-I hypersensitivity sites and distal to known
UCSC and Gencode TSS.
(XLS)
Table S7 IMR90 enhancers predicted using all 24
modifications.
(XLS)
Table S8 All p300 binding-sites called using MACS in
CD4+ T-cells (hg18).
(XLS)
Table S9 p300 binding sites in CD4 T-cells overlapping
DNase-I hypersensitivity sites and distal to known
UCSC and Gencode TSS.
(XLS)
Table S10 CBP binding sites determined by MACS.
(XLS)
Table S11 CD4 enhancer predictions using RFECS with
H3K27ac, H3K4me1 and H3K4me3 and peak filtering
distance as 1 kb.
(XLS)
Table S12 CD4 enhancer predictions by Chromia using
H3K27ac, H3K4me1 and H3K4me3.
(XLS)
Table S13 DNase-I hotspots in IMR90 (hg19).
(TXT)
Table S14 Enhancer predictions in the ENCODE cell-
types GM12878, H1, Helas3, Hepg2, Hmec and Hsmm
(hg18).
(PDF)
Table S15 Enhancer predictions in the ENCODE cell-
types Huvec, K562, Nha, Nhdfad, Nhek and Nhlf (hg18).
(PDF)
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